DDReg pharma

DELIVER BETTER DATA TO ENSURE FASTER APPROVAL
DDReg Pharma

Regulatory

Drug Device Products

Drug-Device Products: Navigating through the EU

Drug-device combination (DDC) products are increasingly demonstrating the value they bring in diagnosing, treating, and curing complex diseases. The growth of the DDC market is driven by several factors including an increase in chronic diseases, a well-established medical technology industry, a rise in surgical procedures, the availability of funding for research and innovation etc. As […]

Drug-Device Products: Navigating through the EU Read More »

Digital Health Technology

Indian Perspective on Digital Health Technology

Digital health technology has gained significant momentum in India, revolutionizing healthcare delivery and improving accessibility and efficiency. It acts as a fundamental support for providing value-based care throughout the healthcare system. Various digital health technologies, including telemedicine and health monitoring apps, are transforming the healthcare landscape in India.The Indian Prime Minister introduced the National Digital

Indian Perspective on Digital Health Technology Read More »

Digital Health Technology

Challenges With Medical Devices and Digital Health Technologies

Currently, there are over 2 million diverse types of medical devices accessible in the global market, which are further classified into more than 7000 generic device groups. As of 2021, the worldwide medical devices market was valued at USD 488.98 billion and is predicted to grow at a compound annual growth rate (CAGR) of 5.5%

Challenges With Medical Devices and Digital Health Technologies Read More »

Monitoring Clinical Trials

Risk-Based Approach to Monitoring Clinical Trials

Introduction Clinical trial sponsors for pharmaceutical products (drugs and/or biologics for human use, medical devices, combination products etc) are required to provide the oversight for monitoring a clinical trial to help make sure that the rights, safety, and welfare of trial participants are protected. For this, sponsors are required to implement a system that manages

Risk-Based Approach to Monitoring Clinical Trials Read More »

Digital Future of Healthcare

Digital Future of Healthcare

Introduction The COVID-19 pandemic and changes in legal frameworks have sparked and accelerated the major trend of digitalization in the health sector. This trend is expected to result in merging digital products, including medicinal products and medical devices, into a digital ecosystem supported by shorter development cycles and technological progress. Digitalization is expected to improve

Digital Future of Healthcare Read More »

Artificial Intelligence

Regulatory Guidelines for Software and Artificial Intelligence as a Medical Device

Technological disruptors are gradually revolutionizing various aspects of life sciences and healthcare. Software is slowly becoming an important part of products and are being integrated into digital platforms for medical and non-medical purposes. There are 3 types of software-related medical devices: 1) Software as a medical device (SaMD), 2) software in a medical device, and

Regulatory Guidelines for Software and Artificial Intelligence as a Medical Device Read More »

Pharmaceutical

WHO Pre-qualification pathway: advancing access to vaccines

Introduction Malaria is one of the biggest and most pressing tropical and infectious diseases that pose a significant  threat to public health- particularly children. In 2019, a study analysis found that malaria caused 643,000 deaths globally with children <5 years of age living in Africa and exhibiting the highest disease burden [1]. According to the

WHO Pre-qualification pathway: advancing access to vaccines Read More »

Pharmacovigilance

DARWIN EU – Generating Real-World Evidence to Support Regulatory Decisions

The European Medicines Agency (EMA) has created a sustainable network called DARWIN EU, which aims to generate real-world evidence to support regulatory decision-making in the European Union. This coordination centre network uses data analysis techniques and real-world interrogation methods to extract information and insights from various data sources, including structured and unstructured sources. Its main

DARWIN EU – Generating Real-World Evidence to Support Regulatory Decisions Read More »

Oncology Therapeutics

Benefits of randomized control trials in accelerated approvals for oncology therapeutics

In 1992 the US FDA established the accelerated approval pathway for drug development as treatment options for serious or life-threatening conditions like cancer based on the effect the drug has on surrogate measures or an intermediate clinical end-point that could predict the real endpoint. However, these investigational drugs are subjected to post-approval confirmatory studies which

Benefits of randomized control trials in accelerated approvals for oncology therapeutics Read More »

Clinical Evaluation Report

Medical Devices – Considerations for preparing a Clinical Evaluation Report (CER)

Overview Medical Device manufacturers must demonstrate the safety, efficacy, and quality, of the product and that it functions as intended without endangering the user or patient. The European Medicines Agency (EMA) mandated a clinical evaluation report (CER) that is required to obtain a CE marking for devices that are to be marketed within the European

Medical Devices – Considerations for preparing a Clinical Evaluation Report (CER) Read More »